Nicholas N. Vahanian
2014
In 2014, Nicholas N. Vahanian earned a total compensation of $2.3M as President & Chief Medical Officer at NewLink Genetics, a 72% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $340,200 |
|---|---|
| Option Awards | $887,667 |
| Salary | $453,600 |
| Stock Awards | $523,810 |
| Other | $47,530 |
| Total | $2,252,807 |
Vahanian received $887.7K in option awards, accounting for 39% of the total pay in 2014.
Vahanian also received $340.2K in non-equity incentive plan, $453.6K in salary, $523.8K in stock awards and $47.5K in other compensation.
Rankings
In 2014, Nicholas N. Vahanian's compensation ranked 4,043rd out of 13,032 executives tracked by ExecPay. In other words, Vahanian earned more than 69.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,043 out of 13,032 | 69th |
Division Manufacturing | 1,429 out of 4,966 | 71st |
Major group Chemicals And Allied Products | 463 out of 1,686 | 73rd |
Industry group Drugs | 358 out of 1,365 | 74th |
Industry Pharmaceutical Preparations | 286 out of 1,043 | 73rd |
Source: SEC filing on March 31, 2017.
Vahanian's colleagues
We found five more compensation records of executives who worked with Nicholas N. Vahanian at NewLink Genetics in 2014.
2014
John Henneman
NewLink Genetics
Chief Financial Officer
2014
Charles Link
NewLink Genetics
Chief Executive & Scientific Officer
2014
W Ramsey
NewLink Genetics
Quality Assurance Officer
2014
Gordon Link
NewLink Genetics
Chief Financial Officer
2014
Brian Wiley
NewLink Genetics